Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Centre Oscar Lambret
NeoImmuneTech
Imperial College London
AbbVie
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
City of Hope Medical Center
Hospices Civils de Lyon
UNC Lineberger Comprehensive Cancer Center
Sahlgrenska University Hospital
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
PharmaMar
Azienda USL Reggio Emilia - IRCCS
National Institute of Cancerología
New Mexico Cancer Research Alliance
Mario Negri Institute for Pharmacological Research
Thomas Jefferson University
Genelux Corporation
Revolution Medicines, Inc.
ARCAGY/ GINECO GROUP
Ohio State University Comprehensive Cancer Center
Immatics US, Inc.
Zymeworks BC Inc.
Compugen Ltd
University of Michigan Rogel Cancer Center
Cyteir Therapeutics, Inc.
Jazz Pharmaceuticals
Eli Lilly and Company
Vincerx Pharma, Inc.
Astellas Pharma Inc
DxTerity Diagnostics
University of Aarhus
Duke University
Cedars-Sinai Medical Center
Advaxis, Inc.
University of Leeds
National Cancer Institute, Egypt
Exelixis
Nucletron Operations BV
Jules Bordet Institute
University of New Mexico
National Cancer Institute (NCI)
Capital Medical University
AstraZeneca
Pfizer
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.